Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising geriatric population and improved life expectancy across the globe
3.2.1.2 Rising adoption of customized medicine in the developed regions
3.2.1.3 Shortage of drugs across the globe
3.2.1.4 Benefits of compounded medication
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of skilled lab technicians and pharmacists in developed economies
3.2.2.2 High cost of equipment and maintenance of sterile environment
3.2.2.3 Volatile regulatory scenario
3.3 Growth potential analysis
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.4.3 Australia
3.5 Reimbursement landscape
3.5.1 U.S.
3.5.2 Europe
3.5.3 Australia
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Oral
5.2.1 Solid preparations
5.2.1.1 Tablets
5.2.1.2 Capsules
5.2.1.3 Granules
5.2.1.4 Powder
5.2.1.5 Other solid preparations
5.2.2 Liquid preparations
5.2.2.1 Solutions
5.2.2.2 Suspension
5.2.2.3 Emulsion
5.2.2.4 Syrup
5.2.2.5 Other liquid preparations
5.3 Topical
5.3.1 Ointments
5.3.2 Creams
5.3.3 Gels
5.3.4 Pastes
5.3.5 Other topical products
5.4 Rectal
5.4.1 Suppositories
5.4.2 Enema
5.4.3 Other rectal products
5.5 Parenteral
5.5.1 Large volume parenterals (LVPs)
5.5.2 Small volume parenterals (LVPs)
5.6 Nasal
5.7 Ophthalmic
5.8 Otic
Chapter 6 Market Estimates and Forecast, By Therapeutic Area, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Pain management
6.3 Hormone replacement
6.4 Dermatology applications
6.5 Specialty drugs
6.6 Nutritional supplements
6.7 Other therapeutic areas
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Adult
7.3 Geriatric
7.4 Veterinary
7.5 Pediatric
Chapter 8 Market Estimates and Forecast, By Compounding Type, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical ingredient alteration (PIA)
8.3 Currently unavailable pharmaceutical manufacturing (CUPM)
8.4 Pharmaceutical dosage alteration (PDA)
8.5 Other compounding types
Chapter 9 Market Estimates and Forecast, By Sterility, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Sterile dosage form
9.3 Non sterile dosage form
Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 Hospital pharmacies
10.3 Compounding pharmacies
10.4 Other distribution channels
Chapter 11 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
11.1 Key trends
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Spain
11.3.5 Italy
11.3.6 Poland
11.3.7 Netherlands
11.3.8 Sweden
11.3.9 Belgium
11.3.10 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 Australia
11.4.5 South Korea
11.4.6 Singapore
11.4.7 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Argentina
11.5.4 Rest of Latin America
11.6 Middle East and Africa
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 UAE
11.6.4 Qatar
11.6.5 Rest of Middle East and Africa
Chapter 12 Company Profiles
12.1 B. Braun Melsungen AG
12.2 Clinigen Group PLC
12.3 Dougherty's Pharmacy, Inc.
12.4 Fagron NV
12.5 Fresenius Kabi AG
12.6 ITC Compounding Pharmacy
12.7 Institutional Pharmacy Solutions, LLC
12.8 Lorraine’s Pharmacy
12.9 McGuff Compounding Pharmacy Services
12.10 Nephron Pharmaceuticals Corporation
12.11 Pencol Compounding Pharmacy
12.12 Rx3 Compounding Pharmacy
12.13 Triangle Compounding Pharmacies
12.14 Valor Compounding Pharmacy, Inc.
12.15 Wedgewood Village Pharmacy, Inc.
